Ignite Creation Date:
2025-12-24 @ 11:03 PM
Ignite Modification Date:
2026-05-19 @ 5:33 PM
Study NCT ID:
NCT00669669
Status:
TERMINATED
Last Update Posted:
2022-05-18
First Post:
2008-04-29
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
O6-Benzylguanine-Mediated Tumor Sensitization With Chemoprotected Autologous Stem Cell in Treating Patients With Malignant Gliomas
Sponsor:
Fred Hutchinson Cancer Center
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
2000.00
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None